These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

345 related items for PubMed ID: 1671393

  • 1. Interleukin 1 induces prolonged L-arginine-dependent cyclic guanosine monophosphate and nitrite production in rat vascular smooth muscle cells.
    Beasley D, Schwartz JH, Brenner BM.
    J Clin Invest; 1991 Feb; 87(2):602-8. PubMed ID: 1671393
    [Abstract] [Full Text] [Related]

  • 2. Interleukin 1 activates soluble guanylate cyclase in human vascular smooth muscle cells through a novel nitric oxide-independent pathway.
    Beasley D, McGuiggin M.
    J Exp Med; 1994 Jan 01; 179(1):71-80. PubMed ID: 7505803
    [Abstract] [Full Text] [Related]

  • 3. Inducible nitric oxide synthase in vascular smooth muscle cells from prehypertensive spontaneously hypertensive rats.
    Singh A, Sventek P, Larivière R, Thibault G, Schiffrin EL.
    Am J Hypertens; 1996 Sep 01; 9(9):867-77. PubMed ID: 8879343
    [Abstract] [Full Text] [Related]

  • 4. Tumor necrosis factor alpha activates soluble guanylate cyclase in bovine glomerular mesangial cells via an L-arginine-dependent mechanism.
    Marsden PA, Ballermann BJ.
    J Exp Med; 1990 Dec 01; 172(6):1843-52. PubMed ID: 1979590
    [Abstract] [Full Text] [Related]

  • 5. Interleukin 1 induces prostacyclin-dependent increases in cyclic AMP production and does not affect cyclic GMP production in human vascular smooth muscle cells.
    Beasley D, McGuiggin ME.
    Cytokine; 1995 Jul 01; 7(5):417-26. PubMed ID: 7578979
    [Abstract] [Full Text] [Related]

  • 6. Interleukin 1 and endotoxin activate soluble guanylate cyclase in vascular smooth muscle.
    Beasley D.
    Am J Physiol; 1990 Jul 01; 259(1 Pt 2):R38-44. PubMed ID: 1695820
    [Abstract] [Full Text] [Related]

  • 7. Escherichia coli lipopolysaccharide downregulates soluble guanylate cyclase in pulmonary artery smooth muscle.
    Scott WS, Nakayama DK.
    J Surg Res; 1998 Dec 01; 80(2):309-14. PubMed ID: 9878330
    [Abstract] [Full Text] [Related]

  • 8. Arginine vasopressin inhibits interleukin-1 beta-stimulated nitric oxide and cyclic guanosine monophosphate production via the V1 receptor in cultured rat vascular smooth muscle cells.
    Kusano E, Tian S, Umino T, Tetsuka T, Ando Y, Asano Y.
    J Hypertens; 1997 Jun 01; 15(6):627-32. PubMed ID: 9218182
    [Abstract] [Full Text] [Related]

  • 9. Platelet inhibition by an L-arginine-derived substance released by IL-1 beta-treated vascular smooth muscle cells.
    Durante W, Schini VB, Scott-Burden T, Junquero DC, Kroll MH, Vanhoutte PM, Schafer AI.
    Am J Physiol; 1991 Dec 01; 261(6 Pt 2):H2024-30. PubMed ID: 1661096
    [Abstract] [Full Text] [Related]

  • 10. Interleukin-4 stimulates cGMP production by IFN-gamma-activated human monocytes. Involvement of the nitric oxide synthase pathway.
    Kolb JP, Paul-Eugene N, Damais C, Yamaoka K, Drapier JC, Dugas B.
    J Biol Chem; 1994 Apr 01; 269(13):9811-6. PubMed ID: 7511593
    [Abstract] [Full Text] [Related]

  • 11. L-arginine stimulates cyclic guanosine 3',5'-monophosphate formation in rat islets of Langerhans and RINm5F insulinoma cells: evidence for L-arginine:nitric oxide synthase.
    Laychock SG, Modica ME, Cavanaugh CT.
    Endocrinology; 1991 Dec 01; 129(6):3043-52. PubMed ID: 1683279
    [Abstract] [Full Text] [Related]

  • 12. Nitric oxide from vascular smooth muscle cells: regulation of platelet reactivity and smooth muscle cell guanylate cyclase.
    Mollace V, Salvemini D, Anggard E, Vane J.
    Br J Pharmacol; 1991 Nov 01; 104(3):633-8. PubMed ID: 1724627
    [Abstract] [Full Text] [Related]

  • 13. Nitric oxide mediates interleukin-1-induced prostaglandin E2 production by vascular smooth muscle cells.
    Inoue T, Fukuo K, Morimoto S, Koh E, Ogihara T.
    Biochem Biophys Res Commun; 1993 Jul 15; 194(1):420-4. PubMed ID: 8392840
    [Abstract] [Full Text] [Related]

  • 14. Evidence that an L-arginine/nitric oxide dependent elevation of tissue cyclic GMP content is involved in depression of vascular reactivity by endotoxin.
    Fleming I, Julou-Schaeffer G, Gray GA, Parratt JR, Stoclet JC.
    Br J Pharmacol; 1991 May 15; 103(1):1047-52. PubMed ID: 1678981
    [Abstract] [Full Text] [Related]

  • 15. Insulin increases NO-stimulated guanylate cyclase activity in cultured VSMC while raising redox potential.
    Kahn AM, Allen JC, Seidel CL, Lichtenberg DS, Song T, Zhang S.
    Am J Physiol Endocrinol Metab; 2000 Apr 15; 278(4):E627-33. PubMed ID: 10751195
    [Abstract] [Full Text] [Related]

  • 16. Nitric oxide enhances PGI(2)production by human pulmonary artery smooth muscle cells.
    Wen F, Watanabe K, Yoshida M.
    Prostaglandins Leukot Essent Fatty Acids; 2000 Jun 15; 62(6):369-78. PubMed ID: 10913230
    [Abstract] [Full Text] [Related]

  • 17. Adrenergic stimulation of cyclic GMP formation requires NO-dependent activation of cytosolic guanylate cyclase in rat pinealocytes.
    Spessert R, Layes E, Vollrath L.
    J Neurochem; 1993 Jul 15; 61(1):138-43. PubMed ID: 8099948
    [Abstract] [Full Text] [Related]

  • 18. Nitric oxide and cyclic GMP formation induced by interleukin 1 beta in islets of Langerhans. Evidence for an effector role of nitric oxide in islet dysfunction.
    Corbett JA, Wang JL, Hughes JH, Wolf BA, Sweetland MA, Lancaster JR, McDaniel ML.
    Biochem J; 1992 Oct 01; 287 ( Pt 1)(Pt 1):229-35. PubMed ID: 1384465
    [Abstract] [Full Text] [Related]

  • 19. Growth hormone-releasing factor increases somatostatin release and mRNA levels in the rat periventricular nucleus via nitric oxide by activation of guanylate cyclase.
    Aguila MC.
    Proc Natl Acad Sci U S A; 1994 Jan 18; 91(2):782-6. PubMed ID: 7904758
    [Abstract] [Full Text] [Related]

  • 20. Natriuretic peptide-augmented induction of nitric oxide synthase through cyclic guanosine 3',5'-monophosphate elevation in vascular smooth muscle cells.
    Marumo T, Nakaki T, Hishikawa K, Hirahashi J, Suzuki H, Kato R, Saruta T.
    Endocrinology; 1995 May 18; 136(5):2135-42. PubMed ID: 7536663
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.